OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study
Hauke Basedau, Lisa-Marie Sturm, Jan Mehnert, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
Hauke Basedau, Lisa-Marie Sturm, Jan Mehnert, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 162
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 162
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA
David W. Dodick, Peter J. Goadsby, Todd J. Schwedt, et al.
The Lancet (2023) Vol. 402, Iss. 10419, pp. 2307-2316
Closed Access | Times Cited: 37
David W. Dodick, Peter J. Goadsby, Todd J. Schwedt, et al.
The Lancet (2023) Vol. 402, Iss. 10419, pp. 2307-2316
Closed Access | Times Cited: 37
Mode and site of action of therapies targeting CGRP signaling
Alejandro Labastida‐Ramírez, Edoardo Caronna, Cédric Gollion, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 33
Alejandro Labastida‐Ramírez, Edoardo Caronna, Cédric Gollion, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 33
Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study
Andreas Straube, Gregor Broessner, Charly Gaul, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Andreas Straube, Gregor Broessner, Charly Gaul, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Atogepant: Mechanism of action, clinical and translational science
Ramesh Boinpally, Mohamad Shebley, Joel M. Trugman
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Ramesh Boinpally, Mohamad Shebley, Joel M. Trugman
Clinical and Translational Science (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Switching CGRP(r) MoAbs in migraine: what evidence?
William Wells-Gatnik, Paolo Martelletti
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 327-333
Closed Access | Times Cited: 9
William Wells-Gatnik, Paolo Martelletti
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 327-333
Closed Access | Times Cited: 9
Is there a role of calcitonin gene-related peptide in cortical spreading depression mechanisms?– Argument pro
Marina Romozzi, Paolo Calabresi
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Marina Romozzi, Paolo Calabresi
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics
William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 19
Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine
Michał Fila, Anna Sobczuk, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6151-6151
Open Access | Times Cited: 26
Michał Fila, Anna Sobczuk, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6151-6151
Open Access | Times Cited: 26
Effect of anti‐CGRP ‐targeted therapy on migraine aura: Results of an observational case series study
Elena Cresta, Alessia Bellotti, Giovanni Rinaldi, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 5
Elena Cresta, Alessia Bellotti, Giovanni Rinaldi, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 5
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
Armin Scheffler, P Wenzel, Merle Bendig, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Armin Scheffler, P Wenzel, Merle Bendig, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine
Simona Nikolova, Catherine D. Chong, Gina Dumkrieger, et al.
Cephalalgia (2023) Vol. 43, Iss. 2
Open Access | Times Cited: 11
Simona Nikolova, Catherine D. Chong, Gina Dumkrieger, et al.
Cephalalgia (2023) Vol. 43, Iss. 2
Open Access | Times Cited: 11
Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study
Hauke Basedau, Kuan‐Po Peng, Marlene Schellong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Hauke Basedau, Kuan‐Po Peng, Marlene Schellong, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
Matteo Conti, Roberta Bovenzi, Maria Giuseppina Palmieri, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 825-837
Open Access | Times Cited: 4
Matteo Conti, Roberta Bovenzi, Maria Giuseppina Palmieri, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 825-837
Open Access | Times Cited: 4
Switching between anti-cgrp monoclonal antibodies in migraine prophylaxis
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Cortical astrocyte activation triggers meningeal nociception and migraine-like pain
Dara Bree, Jun Zhao, Jennifer Stratton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Dara Bree, Jun Zhao, Jennifer Stratton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients
Edina Szabó, Nicolas R. Bolo, David Borsook, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access
Edina Szabó, Nicolas R. Bolo, David Borsook, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access
Imaging of Migraine and Vestibular Migraine
Roberta Messina, Maria A. Rocca, Massimo Filippi
(2025), pp. 185-202
Closed Access
Roberta Messina, Maria A. Rocca, Massimo Filippi
(2025), pp. 185-202
Closed Access
Efficacy of anti-calcitonin gene-related peptide monoclonal antibodies in hemiplegic migraine: a case report and review of literature
Máté Héja, László Oláh
Frontiers in Neurology (2025) Vol. 16
Open Access
Máté Héja, László Oláh
Frontiers in Neurology (2025) Vol. 16
Open Access
Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab
Todd J. Schwedt, Simona Nikolova, Gina Dumkrieger, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Todd J. Schwedt, Simona Nikolova, Gina Dumkrieger, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response
Gabriella Juhász, Kinga Gecse, Dániel Baksa
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108523-108523
Open Access | Times Cited: 10
Gabriella Juhász, Kinga Gecse, Dániel Baksa
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108523-108523
Open Access | Times Cited: 10
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine
Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 386-386
Open Access | Times Cited: 3
Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 386-386
Open Access | Times Cited: 3
What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
Marta Waliszewska‐Prosół, Doğa Vurallı, Paolo Martelletti
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Marta Waliszewska‐Prosół, Doğa Vurallı, Paolo Martelletti
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Imaging the brain and vascular reactions to headache treatments: a systematic review
Roberta Messina, René Christensen, I. Cetta, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Roberta Messina, René Christensen, I. Cetta, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7
